Refine
Has Fulltext
- yes (27)
Is part of the Bibliography
- yes (27)
Year of publication
Document Type
- Journal article (27)
Language
- English (27)
Keywords
- T cells (4)
- GvHD (2)
- Multiple myeloma (2)
- alloreactive T cells (2)
- cancer (2)
- immune cells (2)
- mouse models (2)
- regulatory T cells (2)
- Activation (1)
- Allogeneic stem cell transplantation (1)
- Alpha therapy (1)
- Aspergillus (1)
- Autoimmune diseases (1)
- B cells (1)
- BRAF mutation (1)
- Bioluminescence (1)
- Bioluminescence imaging (1)
- Bone marrow cells (1)
- Bone marrow transplantantation (1)
- Bone marrow transplantation (1)
- CD11b+ myeloid cells (1)
- CNS cancer (1)
- CRISPR/Cas9 (1)
- Cancer treatment (1)
- Capicua transcriptional repressor (1)
- Drug resistance (1)
- Expression (1)
- Extramedullary disease (1)
- Factor receptor (1)
- Fak regulation (1)
- GVHD (1)
- Graft-versus-host disease (1)
- Graft-versus-leukemia (1)
- IRF4 (1)
- Immunology (1)
- Induced apoptosis (1)
- Infectious disease (1)
- Lichtheimia (1)
- Lymphomas (1)
- MPI (1)
- MPS (1)
- Mechanisms (1)
- Medizin (1)
- Migration (1)
- Minor histocompatibility antigen mismatch transplantation (1)
- Multiple (1)
- NF-Kappa-B (1)
- NFAT (1)
- NFATc1 (1)
- Parkinson's disease (1)
- Pathogenesis (1)
- Phase- (1)
- Regulatory-cells (1)
- Rheumatoid arthritis (1)
- Spleen (1)
- Stromal cells (1)
- Suppression (1)
- T-cell transfer (1)
- TNF (1)
- TNFR family costimulatory receptors (1)
- TNFR2 (1)
- TNFR2 agonists (1)
- TNFR2 antagonism (1)
- Tregs (regulatory T cells) (1)
- Trypanosoma (1)
- Tumor-necrosis-factor (1)
- VLA-1 (1)
- acute graft-versus host disease (1)
- acute graft-versus-host disease (1)
- agonist (1)
- anaplastic medulloblastoma (1)
- animal model (1)
- antigen-presenting cells (1)
- aspergillus fumigatus (1)
- autologous transplantation (1)
- biomarkers Myelomas (1)
- biophysics (1)
- bone imaging (1)
- bone marrow (1)
- bortezomib plus dxamethasone (1)
- brain tumor (1)
- calcofluor white staining (1)
- cancer microenvironment (1)
- cancer stem cells (1)
- cancer treatment (1)
- cell staining (1)
- cereblon expression (1)
- children (1)
- corticosteroids and cyclophosphamide (1)
- crosslinked coating (1)
- cytokines (1)
- cytotoxic T cells (1)
- elderly patients (1)
- fluorescence microscopy (1)
- fluorescent dyes (1)
- fungal infection model (1)
- gRNA-only (1)
- gene regulation (1)
- graft vs. host disease (1)
- group 3 (1)
- homing (1)
- imaging agents (1)
- immune cell recruitment (1)
- immune control (1)
- immunotherapy (1)
- lymph node stromal cells (1)
- lymph node transplantation (1)
- lymphocyte activation (1)
- magnetic properties (1)
- megakaryocytes (1)
- mesenteric lymph node (1)
- metabolism (1)
- metastasis (1)
- microswimmer (1)
- monoclonal gammopathy (1)
- multiparameter flow-cytpmetry (1)
- multiple myeloma Lesions (1)
- myeloid-derived suppressor cells (MDSCs) (1)
- myeloma cells (1)
- naive T-cell gene editing (1)
- neuroimmunology (1)
- none (1)
- orthotopic xenograft (1)
- paediatric cancer (1)
- prediction (1)
- randomized phase-3 trial (1)
- serum retention (1)
- signal transduction (1)
- silkworm (1)
- sleeping sickness (1)
- spleen (1)
- stem-cell transplantation (1)
- structural biology (1)
- thalidomide maintenance (1)
- thrombopoiesis (1)
- transient regulatory T-cell targeting (1)
- transplantation (1)
- tsetse fly (1)
- tumour immunology (1)
- undetermined significance MGUS (1)
Institute
- Medizinische Klinik und Poliklinik II (25)
- Pathologisches Institut (7)
- Institut für Virologie und Immunbiologie (6)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (5)
- Kinderklinik und Poliklinik (5)
- Graduate School of Life Sciences (4)
- Theodor-Boveri-Institut für Biowissenschaften (4)
- Rudolf-Virchow-Zentrum (3)
- Neurochirurgische Klinik und Poliklinik (2)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 825575 (1)
Immune checkpoint blockade therapy is beneficial and even curative for some cancer patients. However, the majority don’t respond to immune therapy. Across different tumor types, pre-existing T cell infiltrates predict response to checkpoint-based immunotherapy. Based on in vitro pharmacological studies, mouse models and analyses of human melanoma patients, we show that the cytokine GDF-15 impairs LFA-1/β2-integrin-mediated adhesion of T cells to activated endothelial cells, which is a pre-requisite of T cell extravasation. In melanoma patients, GDF-15 serum levels strongly correlate with failure of PD-1-based immune checkpoint blockade therapy. Neutralization of GDF-15 improves both T cell trafficking and therapy efficiency in murine tumor models. Thus GDF-15, beside its known role in cancer-related anorexia and cachexia, emerges as a regulator of T cell extravasation into the tumor microenvironment, which provides an even stronger rationale for therapeutic anti-GDF-15 antibody development.